Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,876 | -31,807 | -34,336 | -111,118 | -74,080 |
| Depreciation Amortization | 7,359 | 3,615 | 22,489 | 18,610 | 11,820 |
| Accounts receivable | 2,362 | 5,365 | 10,476 | 13,122 | 9,570 |
| Accounts payable and accrued liabilities | -5,513 | -8,095 | 6,181 | -1,476 | -1,727 |
| Other Working Capital | -19,307 | -16,642 | -26,794 | -30,271 | -37,719 |
| Other Operating Activity | 7,898 | 5,170 | -123,798 | -3,932 | -4,289 |
| Operating Cash Flow | $-71,077 | $-42,394 | $-145,782 | $-115,065 | $-96,425 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,999 | -5,104 | -18,855 | -15,064 | -10,349 |
| Net Acquisitions | N/A | N/A | 114,831 | N/A | N/A |
| Purchase Of Investment | -186,016 | -85,298 | -479,552 | -415,653 | -334,685 |
| Sale Of Investment | 229,575 | 104,458 | 658,228 | 534,938 | 397,927 |
| Other Investing Activity | -4,440 | -4,766 | 0 | 0 | 0 |
| Investing Cash Flow | $31,120 | $9,290 | $274,652 | $104,221 | $52,893 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -616 | -302 | -50,125 | -1,910 | -1,151 |
| Common Stock Issued | 90 | 61 | 384 | 477 | 383 |
| Financing Cash Flow | $-526 | $-241 | $-49,741 | $-1,433 | $-768 |
| Exchange Rate Effect | -109 | 61 | 162 | -303 | -164 |
| Beginning Cash Position | 155,584 | 155,584 | 76,293 | 76,293 | 76,293 |
| End Cash Position | 114,992 | 122,300 | 155,584 | 63,713 | 31,829 |
| Net Cash Flow | $-40,592 | $-33,284 | $79,291 | $-12,580 | $-44,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,077 | -42,394 | -145,782 | -115,065 | -96,425 |
| Capital Expenditure | -7,999 | -5,104 | -18,855 | -15,064 | -10,349 |
| Free Cash Flow | -79,076 | -47,498 | -164,637 | -130,129 | -106,774 |